Alexandra Deubel

Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma

J. Utikal, D. Jäger, Ö. Türeci, 2018, Clinical Trials.